Investigating the association between IL-6 antagonist therapy and blood coagulation in critically ill patients with COVID-19: a protocol for a prospective, observational, multicentre study.

导出 OA

翻译打印收藏纠错

作者： Emőke Henrietta,Kovács ^[1] ; Máté,Rottler ^[2] ; Fanni,Dembrovszky ^[3] ; Klementina,Ocskay ^[4] ; László,Szabó ^[1] ; Péter,Hegyi ^[5] ; Zsolt,Molnár ^[1] ; Krisztián,Tánczos ^[5]

作者单位： Centre for Translational Medicine, Semmelweis University, Budapest, Hungary. ^[1] Selye János Doctoral College for Advanced Studies, Semmelweis University, Budapest, Hungary. ^[2] Department of Anaesthesiology and Intensive Therapy, Semmelweis University, Budapest, Hungary. ^[3] Szent György University Teaching Hospital of Fejér County, Székesfehérvár, Hungary. ^[4] Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary. ^[5] Division of Pancreatic Diseases, Heart and Vascular Center, Semmelweis University, Budapest, Hungary. ^[6] Department of Anaesthesiology and Intensive Therapy, Poznan University of Medical Sciences, Poznan, Poland. ^[7] Department of Anaesthesiology and Intensive Therapy, Semmelweis University, Budapest, Hungary tkrisztian78@gmail.com. ^[8] Soproni Erzsébet Teaching Hospital and Rehabilitation Institute, Sopron, Hungary. ^[9]

关键词 Adult intensive & critical care Bleeding disorders & coagulopathies COVID-19

主题词人类(Humans);血液凝固(Blood Coagulation);危重病(Critical Illness);白细胞介素6(Interleukin-6);多中心研究(主题)(Multicenter Studies as Topic);前瞻性研究(Prospective Studies)

DOI 10.1136/bmjopen-2022-063856

PMID 36332964

发布时间 2022-12-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交